Literature DB >> 30864110

Color Doppler imaging of ocular hemodynamic changes in patients with rheumatoid arthritis unrelated to disease activity.

Ozlem Unal1, Mehmet Erol Can2, Aysenur Ozcan3, Meltem Ece Ozcan4, Sukran Erten5, Nurullah Cagil6.   

Abstract

We aimed to investigate how orbital blood flow rates in patients with rheumatoid arthritis (RA) are affected by the active and remission phase of the disease. This prospective study included a total of 56 patients with RA (study group) and 24 control individuals (control group). All RA patients were divided into two groups, as active (Group 1) and remission (Group 2) according to the disease activity index (DAS 28) score. For each eye, retrobulbar vascular structures were evaluated [central retinal artery (CRA), posterior ciliary artery (PCA), and ophthalmic artery (OA)], respectively. The peak systolic velocity (PSV) and end-diastolic velocity (EDV) values were obtained for each artery and the vascular resistance index (RI) measurement was calculated. The median RI of the OA was 0.70 (0.57; 0.79) in the control group, 0.77 (0.55; 0.87) in group 1, and 0.73 (0.47; 0.87) in group 2. The median RI in the PCA was 0.70 (0.56; 0.82) in the control group, 0.76 (0.52; 0.88) in the group 1, and 0.74 (0.52; 0.86) in the group 2. The median RI of CRA was 0.73 (0.48; 0.81) in the control group, 0.71 (0.64; 0.81) in group 1, and 0.68 (0.61; 0.85) in group 2. The RI value was a significant difference between control and group 1 (p < 0.05). Active and remission RA patients had different effects on the flow rate of eye blood vessels.

Entities:  

Keywords:  Blood flow rate; Doppler ultrasonography; Rheumatoid arthritis; Vascular structures

Mesh:

Year:  2019        PMID: 30864110     DOI: 10.1007/s00296-019-04275-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  32 in total

1.  Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes.

Authors:  T O'Malley; C A Ludlam; R A Riemermsa; K A Fox
Journal:  Eur Heart J       Date:  2001-07       Impact factor: 29.983

2.  Multiple occlusive retinal arteritis in both eyes of a patient with rheumatoid arthritis.

Authors:  T Matsuo
Journal:  Jpn J Ophthalmol       Date:  2001 Nov-Dec       Impact factor: 2.447

3.  Anterior ischaemic optic neuropathy in patient with rheumatoid arthritis--case report.

Authors:  S Perić; B Cerovski; P Perić
Journal:  Coll Antropol       Date:  2001

Review 4.  Ophthalmologic manifestations of rheumatic diseases.

Authors:  F Hamideh; P E Prete
Journal:  Semin Arthritis Rheum       Date:  2001-02       Impact factor: 5.532

5.  Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.

Authors:  Solveig Wållberg-Jonsson; Jasmina Trifunovic Cvetkovic; Karl-Gösta Sundqvist; Ann Kari Lefvert; Solbritt Rantapää-Dahlqvist
Journal:  J Rheumatol       Date:  2002-05       Impact factor: 4.666

Review 6.  Management of extra-articular disease manifestations in rheumatoid arthritis.

Authors:  Carl Turesson; Eric L Matteson
Journal:  Curr Opin Rheumatol       Date:  2004-05       Impact factor: 5.006

7.  Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.

Authors:  James B Meigs; Frank B Hu; Nader Rifai; JoAnn E Manson
Journal:  JAMA       Date:  2004-04-28       Impact factor: 56.272

8.  Biological determinants of serum ICAM-1, E-selectin, P-selectin and L-selectin levels in healthy subjects: the Stanislas study.

Authors:  Anne Ponthieux; Bernard Herbeth; Suzanne Droesch; Nadia Haddy; Daniel Lambert; Sophie Visvikis
Journal:  Atherosclerosis       Date:  2004-02       Impact factor: 5.162

9.  Synovial membrane and fluid morphologic alterations in early rheumatoid arthritis: microvascular injury and virus-like particles.

Authors:  H R Schumacher
Journal:  Ann N Y Acad Sci       Date:  1975-06-13       Impact factor: 5.691

10.  Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis.

Authors:  Patrick H Dessein; Barry I Joffe; Sham Singh
Journal:  Arthritis Res Ther       Date:  2005-03-24       Impact factor: 5.156

View more
  1 in total

1.  The association of choroidal thickness with rheumatoid factor and anti-cyclic citrullinated peptide in rheumatoid arthritis.

Authors:  Arif Ülkü Yener; Kubilay Şahin
Journal:  Int Ophthalmol       Date:  2020-01-11       Impact factor: 2.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.